[et_pb_section fb_built=”1″ _builder_version=”3.21.4″][et_pb_row _builder_version=”3.21.4″][et_pb_column type=”4_4″ _builder_version=”3.21.4″][et_pb_video src=”https://www.youtube.com/watch?v=ScLstXAWzMQ&feature=youtu.be” _builder_version=”3.21.4″][/et_pb_video][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”3.21.4″][et_pb_column type=”4_4″ _builder_version=”3.21.4″][et_pb_text _builder_version=”3.21.4″]
Mushrooms may reduce the risk of cognitive decline by 50%
A team from the Department of Psychological Medicine and Department of Biochemistry at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS) has found that seniors who consume more than two standard portions of mushrooms weekly may have 50 per cent reduced odds of having mild cognitive impairment (MCI).
“We’re very interested in a compound called ergothioneine (ET),” said Dr Irwin Cheah, Senior Research Fellow at the NUS Department of Biochemistry. “ET is a unique antioxidant and anti-inflammatory which humans are unable to synthesize on their own. But it can be obtained from dietary sources, one of the main ones being mushrooms.”
Lei Feng, Irwin Kee-Mun Cheah, Maisie Mei-Xi Ng, Jialiang Li, Sue Mei Chan, Su Lin Lim, Rathi Mahendran, Ee-Heok Kua, Barry Halliwell. The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore. Journal of Alzheimer’s Disease, 2019; 1 DOI: 10.3233/JAD-180959
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad180959
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]